Skip to main content
. 2020 Oct 17;20:346. doi: 10.1186/s12876-020-01485-8

Table 3.

Serum 25(OH)VD levels in CHC patients at baseline and after DAA curative treatment comparing cirrhotic and non-cirrhotic patients

Week 0 (ng/mL) Week 24 (ng/mL) Week 48a (ng/mL)
Cirrhotic (n = 63) 25.0 ± 10.5 20.2 ± 8.1 19.9 ± 8.2
Non-cirrhotic (n = 17) 31.0 ± 10.3 22.8 ± 7.7 24.1 ± 9.4
p value 0.039 0.251 0.087

aSix patients were lost to follow-up at 48 weeks; 5 in cirrhotic group and 1 in non-cirrhotic group